Search
for
Sort by
Research 361–390 of 1000+
- Heterozygous FOXN1 Variants Cause Low TRECs and Severe T Cell Lymphopenia, Revealing a Crucial Role of FOXN1 in Supporting Early Thymopoiesis
- Efficacy of Platelet-Rich Plasma Therapy in Oral Lichen Planus: A Systematic Review
- Cure of alopecia areata after eradication of Helicobacter pylori: a new association?
- A randomized controlled, single-observer blinded study to determine the efficacy of topical minoxidil plus microneedling versus topical minoxidil alone in the treatment of androgenetic alopecia
- Monilethrix: a typical case report with microscopic and dermatoscopic findings
- A Study to Evaluate the Efficacy of Various Topical Treatment Modalities for Alopecia Areata
- Janus kinase inhibition for the treatment of refractory frontal fibrosing alopecia: A case series and review of the literature
- Long‐term outcome after hand and forearm transplantation – a retrospective study
- Survey on adverse events associated with drug therapy for breast cancer patients
- Successful treatment of epidermal growth factor receptor inhibitor–induced alopecia with doxycycline
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- Clinical Presentations and Comorbidities of Pediatric Alopecia Areata
- Comparative Efficacy Study Combination of Oral Methotrexate and Prednisolone versus Oral Methotrexate in Patients with Lichen Planopilaris
- Monilethrix, a rare inherited hair shaft disorder in siblings
- Concordance between clinician-reported and patient-reported outcomes of eyebrow and eyelash hair loss in patients with severe alopecia areata: Results from BRAVE-AA1 and BRAVE-AA2 studies
- Exome analysis for Cronkhite-Canada syndrome: A case report
- Systemic Tofacitinib in Alopecia Areata: A Single Center Retrospective Descriptive Cohort Study
- Co-occurrence of monilethrix and Type 1 diabetes mellitus
- Use of the drug Wolvit® (biotin 5 mg) in treatment of defuse telogenous alopecia
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Cronkhite–Canada Syndrome With Multiple Mesenteric Lymphadenopathy: A Case Report
- Erythroderma, Alopecia, Anhidrosis, and Vitiligo as Complications of a Red Ink Tattoo—A Case Report
- A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes
- When JAK inhibitors are off the table: durable remission of severe alopecia areata with dexamethasone oral mini-pulse and a focused review
- Case Report: A novel KRT74 variant in an eight-year-old boy with alopecia totalis successfully treated with baricitinib
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- The Frontal Fibrosing Alopecia Syndrome: How a Single Word Name Change Might Change So Much
- Caffeine as an Active Ingredient in Cosmetic Preparations Against Hair Loss: A Systematic Review of Available Clinical Evidence
- Real-life effectiveness and safety of baricitinib in 17 Japanese patients with alopecia areata: a 60-week single center study